Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh
· Delayed Price · Currency is BDT 56.20
+1.30 (2.37%)
At close: Mar 9, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 6.04 billion as of March 9, 2026. Its market cap has increased by 26.29% in one year.
Market Cap
6.04B
Enterprise Value
10.05B
Revenue
9.52B
Ranking
n/a
PE Ratio
11.27
Stock Price
56.20
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 6.04B, an increase of 112.88%. That is a compound annual growth rate of 24.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 6.04B | 8.29% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orion Pharma | 6.55B |
| Asiatic Laboratories | 7.70B |
| Techno Drugs | 3.67B |
| The IBN SINA Pharmaceutical Industry | 9.69B |
| The ACME Laboratories | 16.08B |
| Ambee Pharmaceuticals | 1.79B |
| Pharma Aids | 1.69B |
| Beacon Pharmaceuticals | 22.31B |